Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy and tissue engineering for urologic dysfunction: status and prospects.

T Yokoyama1, M B Chancellor, N Yoshimura

  • 1Department of Urology, Okayama Graduate School of Medicine and Dentistry, Okayama, Japan. uroyoko@hospital.okayama.u.ac.jp

Molecular Urology
|November 3, 2001
PubMed
Summary

Gene therapy and tissue engineering offer promising solutions for urologic dysfunction. These advanced biologic approaches can improve organ function and regenerate damaged genitourinary tissues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of losartan or angiotensin II receptor antagonists on cartilage: a systematic review.

Osteoarthritis and cartilage·2022
Same author

[Impact of the Lubrizol Rouen plant fire of September 26, 2019 on ophthalmic emergency room visits].

Journal francais d'ophtalmologie·2021
Same author

Bone morphogenetic proteins for articular cartilage regeneration.

Osteoarthritis and cartilage·2018
Same author

αv integrins on mesenchymal cells regulate skeletal and cardiac muscle fibrosis.

Nature communications·2017
Same author

Adenovirus vector carrying REIC/DKK-3 gene: neoadjuvant intraprostatic injection for high-risk localized prostate cancer undergoing radical prostatectomy.

Cancer gene therapy·2016
Same author

Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer.

Cancer gene therapy·2016

Area of Science:

  • Regenerative Medicine
  • Urology
  • Biotechnology

Background:

  • Urologic dysfunction presents significant clinical challenges.
  • Gene therapy and tissue engineering are emerging fields with therapeutic potential.
  • Current applications in neurourology are limited compared to urologic oncology.

Purpose of the Study:

  • To review recent advancements in gene therapy and tissue engineering for urologic dysfunction.
  • To highlight the potential of these technologies in treating genitourinary conditions.
  • To discuss the future prospects of these regenerative approaches in urology.

Main Methods:

  • Review of current literature on gene therapy and tissue engineering in urology.
  • Analysis of clinical trial data and preclinical research.

Related Experiment Videos

  • Discussion of biologic approaches utilizing growth factors and gene transfer.
  • Exploration of tissue engineering strategies for genitourinary tissue regeneration.

    • Main Results:

    • Gene therapy shows increasing clinical trial activity in urologic oncology but is less explored in neurourology.
    • Growth factor gene transfer is a promising method for delivering therapeutic proteins to malfunctioning urologic tissues.
    • Tissue engineering offers potential for creating functional genitourinary tissues for regeneration and replacement.
    • Combined gene therapy and tissue engineering approaches present novel solutions for urologic dysfunction.

    Conclusions:

    • Gene therapy and tissue engineering hold significant promise for addressing urologic dysfunction.
    • These advanced biologic strategies can lead to improved organ function and tissue repair.
    • Further research and clinical trials are warranted to fully realize the potential of these regenerative medicine approaches in urology.